Agilent Technologies, Inc. (NYSE:A) Shares Purchased by O Shaughnessy Asset Management LLC

O Shaughnessy Asset Management LLC lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 9.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 37,177 shares of the medical research company’s stock after buying an additional 3,327 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Agilent Technologies were worth $4,994,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of A. CKW Financial Group boosted its stake in Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after buying an additional 100 shares during the last quarter. Global X Japan Co. Ltd. lifted its holdings in shares of Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after acquiring an additional 116 shares during the period. Lee Danner & Bass Inc. purchased a new position in shares of Agilent Technologies during the 4th quarter worth about $29,000. Hanson & Doremus Investment Management boosted its position in shares of Agilent Technologies by 66.5% in the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after acquiring an additional 105 shares during the last quarter. Finally, OFI Invest Asset Management acquired a new position in Agilent Technologies during the fourth quarter worth approximately $37,000.

Wall Street Analyst Weigh In

A has been the topic of a number of research analyst reports. Citigroup lifted their price target on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Robert W. Baird lowered their price target on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research report on Thursday, February 27th. Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and upped their price target for the stock from $135.00 to $145.00 in a research note on Monday, February 10th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $150.83.

Insider Activity

In other news, VP Rodney Gonsalves sold 1,908 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the transaction, the vice president now directly owns 21,786 shares in the company, valued at approximately $2,657,456.28. This trade represents a 8.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This represents a 4.60 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,638 shares of company stock worth $731,229.

Agilent Technologies Stock Up 1.7 %

Shares of Agilent Technologies stock opened at $115.96 on Thursday. Agilent Technologies, Inc. has a 1-year low of $112.75 and a 1-year high of $155.35. The company has a market capitalization of $33.06 billion, a PE ratio of 26.66, a P/E/G ratio of 3.28 and a beta of 1.19. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. The business has a 50-day moving average of $132.16 and a 200-day moving average of $136.18.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s payout ratio is currently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.